United Laboratories International Holdings Placement (3933.HK) - Valuation Pullback Seems Inevitable
United Lab is facing a performance decline when the dividend period of the pandemic has subsided. Weight management/veterinary drug businesses have...
671 Views
Lu DaoPei Medical Group Pre-IPO - Ramp up in Progress but Looks Promising
Lu Daopei Medical Group (1816743D CH) is looking to raise around US$400m in its upcoming Hong Kong IPO. LDPM has supported its growth through its...
525 Views
Shanghai Haohai Biological Technology (688366.CH/6826.HK)- Disappointing Earnings and Gloomy Outlook
Continuous M&A fails to bring ideal performance to Haohai. Medical aesthetics is the main growth driver, but Haohai is lack of competitiveness....
586 Views
Huadong Medicine (000963.CH) 2022H1 - Huadong Is Back on Track. If Shares Pullback, Then Be Long
Huadong released encouraging H1 results.It's back on track. This positive momentum will continue in H2, especially medical cosmetology and...
447 Views
Sihuan Pharmaceutical (460.HK) - The Potential Disposal of Generic Drug Business and the Outlook
The medical aesthetics/innovative drug business face various challenges.Though Sihuan is undervalued,concerns on outlook/development mode will...
429 Views